Freeline Therapeutics (FRLN) Institutional Ownership → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free FRLN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for Freeline Therapeutics (NASDAQ:FRLN)CurrentInstitutional OwnershipPercentage46.26%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$714.19KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$65.37M Get FRLN Insider Trade Alerts Want to know when executives and insiders are buying or selling Freeline Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FRLN Institutional Buying and Selling by Quarter Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here Freeline Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024 PenderFund Capital Management Ltd.60,401$385K0.0%N/A1.391% 1/8/2024 Harbor Capital Advisors Inc.20,352$129K0.0%+62.8%0.469% 11/13/2023CHI Advisors LLC86,654$373K0.1%+300.0%1.997% 8/22/2023CHI Advisors LLC21,666$56K0.0%-99.5%0.499% 7/27/2023 Syncona Portfolio Ltd1,466,508$3.78M5.7%-93.3%33.791% 7/11/2023 Harbor Capital Advisors Inc.10,709$28K0.0%-90.1%0.247% Get the Latest News and Ratings for FRLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Freeline Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023CHI Advisors LLC4,729,419$2.15M0.6%-1.8%7.279% 2/8/2023 Thrivent Financial for Lutherans78,900$37K0.0%N/A0.121% 11/15/2022 TFG Asset Management GP Ltd4,000,000$2.80M0.3%+6.4%6.156% 10/28/2022 Harbor Capital Advisors Inc.131,957$92K0.1%-10.0%0.203% 5/31/2022 Syncona Portfolio Ltd21,997,620$5.84M5.6%+645.7%61.237% 5/17/2022 Eventide Asset Management LLC3,606,192$3.97M0.1%+3.5%10.040% 5/4/2022Prospera Financial Services Inc34,650$39K0.0%+130.3%0.096% 5/3/2022 Values First Advisors Inc.50,149$56K0.0%+117.6%0.140% 4/28/2022 Harbor Capital Advisors Inc.144,672$162K0.1%-20.7%0.403% 3/10/2022 Values First Advisors Inc.23,048$46K0.0%N/A0.064% 2/14/2022 Novo Holdings A S1,776,613$3.52M0.2%-7.9%4.961% 2/11/2022 Syncona Portfolio Ltd2,950,000$5.84M5.6%N/A8.237% 2/4/2022 Harbor Capital Advisors Inc.182,521$360K0.1%N/A0.510% 11/16/2021 Wellington Management Group LLP664,836$2.29M0.0%-66.8%1.857% 11/16/2021CHI Advisors LLC1,427,481$4.87M1.4%+3.5%3.987% 11/15/2021 Marshall Wace LLP356,126$1.23M0.0%N/A0.995% 11/15/2021Veritable L.P.55,870$191K0.0%N/A0.156% 11/15/2021 AXA S.A.566,207$1.93M0.0%+1.9%1.581% 11/12/2021 Renaissance Technologies LLC194,500$663K0.0%N/A0.543% 11/12/2021Prospera Financial Services Inc15,047$51K0.0%N/A0.042% 11/1/2021 SG Americas Securities LLC47,390$163K0.0%N/A0.132% 8/16/2021 Federated Hermes Inc.12,000$98K0.0%-40.0%0.033% 8/11/2021CHI Advisors LLC1,379,843$11.25M2.6%-0.4%3.850% 5/18/2021 Millennium Management LLC66,851$822K0.0%-7.2%0.186% 5/17/2021 Ally Bridge Group NY LLC408,726$5.03M1.0%-3.8%1.140% 5/14/2021 Sectoral Asset Management Inc654,498$8.05M0.6%-0.5%1.825% 2/16/2021 Ovata Capital Management Ltd14,981$274K0.1%-60.1%0.058% 2/13/2021 Polygon Management Ltd.750,000$13.70M0.9%+2.7%2.893% 2/12/2021CHI Advisors LLC1,361,064$24.85M7.0%+2.8%5.251% 2/8/2021 FIL Ltd157,968$2.88M0.0%-40.6%0.440% 11/16/2020 Hound Partners LLC70,000$1.09M0.1%N/A0.270% 11/13/2020 Morgan Stanley13,206$206K0.0%N/A0.051% 11/13/2020 AXA S.A.549,154$8.57M0.0%N/A2.119% 11/13/2020 Ovata Capital Management Ltd37,500$585K0.2%N/A0.145% Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now11/12/2020 Federated Hermes Inc.20,000$312K0.0%N/A0.077% 11/9/2020 Caas Capital Management LP18,166$284K0.0%N/A0.070% 11/5/2020 California Public Employees Retirement System20,152$315K0.0%N/A0.078% (Data available from 1/1/2016 forward) FRLN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FRLN shares? During the previous two years, the following institutional investors and hedge funds held shares of Freeline Therapeutics shares: Syncona Portfolio Ltd ($3.78M), TFG Asset Management GP Ltd ($2.80M), PenderFund Capital Management Ltd. ($385K), CHI Advisors LLC ($373K), and Harbor Capital Advisors Inc. ($129K), Thrivent Financial for Lutherans ($37K).Learn more on FRLN's institutional investors. What percentage of Freeline Therapeutics stock is owned by institutional investors? 46.26% of Freeline Therapeutics stock is owned by institutional investors. Learn more on FRLN's institutional investor holdings. Which institutional investors have been buying Freeline Therapeutics stock? The following institutional investors have purchased Freeline Therapeutics stock in the last 24 months: TFG Asset Management GP Ltd ($239.49K), Thrivent Financial for Lutherans ($78.90K), CHI Advisors LLC ($64.99K), PenderFund Capital Management Ltd. ($60.40K), and Harbor Capital Advisors Inc. ($7.85K). How much institutional buying is happening at Freeline Therapeutics? Institutional investors have bought a total of 451,629 shares in the last 24 months. This purchase volume represents approximately $3.79M in transactions. Which Freeline Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Freeline Therapeutics stock in the last 24 months: Syncona Portfolio Ltd ($20.53M), CHI Advisors LLC ($4.79M), and Harbor Capital Advisors Inc. ($111.63K). How much institutional selling is happening at Freeline Therapeutics? Institutional investors have sold a total of 25,435,492 shares in the last 24 months. This volume of shares sold represents approximately $66.10M in transactions. Related Companies: LianBio Major Shareholders Sol-Gel Technologies Major Shareholders Virios Therapeutics Major Shareholders Alpha Tau Medical Major Shareholders BriaCell Therapeutics Major Shareholders Celularity Major Shareholders Fortress Biotech Major Shareholders Immatics Major Shareholders Jasper Therapeutics Major Shareholders NewAmsterdam Pharma Major Shareholders This page (NASDAQ:FRLN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Freeline Therapeutics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
